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Pseudomonas aeruginosa is a human opportunistic pathogen that causes mortality
in cystic fibrosis and immunocompromised patients. While many virulence factors of
this pathogen have already been identified, several remain to be discovered. In this
respect we set an unprecedented genome-wide screen of a P. aeruginosa expression
library based on a yeast growth phenotype. Fifty-one candidates were selected in
athree-round screening process. The robustness of the screen was validated by the
selection of three well known secreted proteins including one demonstrated virulence
factor, the protease LepA. Further in silico sorting of the 51 candidates highlighted three
potential new Pseudomonas effector candidates (Pec). By testing the cytotoxicity of
wild type P. aeruginosa vs. pec mutants toward macrophages and the virulence in the
Caenorhabditis elegans model, we demonstrated that the three selected Pecs are novel
virulence factors of P. aeruginosa. Additional cellular localization experiments in the host
revealed specific localization for Pec1 and Pec2 that could inform about their respective
functions.
Keywords: Pseudomonas aeruginosa, genome-wide screening in Saccharomyces cerevisiae, Caenorhabditis
elegans model, virulence factors, Pseudomonas effector candidates (Pec)
INTRODUCTION
The bacterium Pseudomonas aeruginosa is the principal Gram-negative causative agent of
nosocomial infection (Driscoll et al., 2007). It is an opportunistic human pathogen causing
acute and chronic infections in immunocompromised individuals. Both invasive and extracellular
P. aeruginosa strains affect host cellular processes by secreting an important arsenal of effector
proteins in the extracellular medium or directly into the host by the means of highly specific
secretion machinery (Bleves et al., 2010).
In the last decade, several high throughput screens have been utilized to identify P. aeruginosa
effectors involved in infection, for instance using: (i) microarrays and RNA-Sequencing to monitor
bacterial gene expression during infection of eukaryotic host cells (Wolfgang et al., 2003; Chugani
and Greenberg, 2007; Wurtzel et al., 2012; Skurnik et al., 2013), (ii) bacterial mutant libraries to
identify virulence-attenuated strains (Feinbaum et al., 2012), (iii) a set of target genes to evaluate
their toxicity when produced in yeast (Arnoldo et al., 2008), (iv) high-throughput sequencing of
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transposon libraries to identify the contribution of individual
genes to the fitness of organisms in different environments
(Skurnik et al., 2013), (v) mass spectrometry identification of
secretomes (Russell et al., 2012), or (vi) bioinformatic approaches
(Jehl et al., 2011; Burstein et al., 2015). However, despite
the high throughput of these approaches, new P. aeruginosa
effectors are still regularly revealed (Sana et al., 2012; Russell
et al., 2013; Faure et al., 2014; Burstein et al., 2015) and many
others certainly remain to be discovered. Their identification
will improve the understanding of P. aeruginosa infection
leading to the development of new alternative therapeutic
strategies.
There are increasing evidences for the utility of the yeast
Saccharomyces cerevisiaemodel to discover new bacterial effector
proteins of human pathogens. This relies on the observation
that the bacterial effector proteins often target cellular processes
that are conserved among eukaryotes, from yeast to human.
Thus, expression of bacterial effector genes in yeast alters yeast
pathways and results in a yeast growth defect, for example,
Pseudomonas aeruginosa ExoU and ExoS (Rabin and Hauser,
2003; Stirling and Evans, 2006), Shigella flexneri IpgB1 and
IpgB2 (Slagowski et al., 2008), Salmonella typhimurium SipA
and SigD (Lesser and Miller, 2001; Aleman et al., 2005),
Chlamydia trachomatis Lda3 (Sisko et al., 2006), Chlamydia
pneumoniae CopN (Huang et al., 2008), enteropathogenic E. coli
EspD and EspG (Rodriguez-Escudero et al., 2005). Interestingly,
the subcellular localization of many ectopically produced
bacterial effector proteins in yeast mimics the localization
of the protein in the host and gives an indication of their
possible functions. For example, the Salmonella SipA was first
identified to localize the yeast actin cytoskeleton and disrupts
its polarity by preventing turnover of actin cables (Lesser
and Miller, 2001). Further studies in mammalian systems
revealed that SipA bundles actin filaments and inhibits their
depolymerization (Galkin et al., 2002). Other advantages have
indeed been accounted for yeast as a valuable tool to analyse
bacterial effector proteins including (i) the ease of cloning by
homologous recombination and transformation, (ii) regulation
of the expression of target genes, (iii) the availability of yeast
mutant strains as well as (iv) the yeast reporter strains for
localization studies, (v) the ease of isolating single colonies from
DNA library-transformed yeast cells and the (vi) availability
of redundant phenotypes of yeast that are defective in certain
pathways.
Despite the increasing number of studies characterizing
known bacterial effectors in yeast, these approaches were only
used to study selected candidates. In this work, we perform for
the first time an unbiased genome-wide screen of P. aeruginosa
PA14 strain to identify potential effector proteins that alter
yeast cellular processes and impair yeast growth. By expressing
in yeast a genomic library of P. aeruginosa PA14, we identify
a set of 51 putative effector proteins and validated 3 of
them that have never been described so far. This successful
study represents the first genome-wide screen of a complete
bacterial genome to identify bacterial effector proteins in
yeast.
MATERIALS AND METHODS
Bacterial Strains, Eukaryotic Strains, Cell
Lines, and Media
For cytotoxicity and C. elegans virulence assays we used the
wild type Escherichia coli OP50 (laboratory collection) strain,
the wild type P. aeruginosa PA14 (Liberati et al., 2006) and
PA141gacA (Garvis et al., 2009) strains as well as the four
PA14 mutants, 23531, 30063, 54050, and 41532 from the PA14
Transposon Insertion Mutant Library (http://ausubellab.mgh.
harvard.edu/cgi-bin/pa14/home.cgi) which respectively possess
a transposon inserted in pec1 (PA14::tn-pec1), pec2 (PA14::tn-
pec2), pec3 (PA14::tn-pec3), and exoU (PA14::tn-exoU). The
Saccharomyces cerevisiae strains used in this study are the wild-
type CEN.PK2 (EUROSCARF) and the mRFP reporter strains
(mRFP-Pex3 and mRFP-Erg3) for colocalization studies (Huh
et al., 2003). Plasmid-bearing strains were grown on selective
synthetic dextrose (SD) medium supplemented with 2% glucose,
raffinose or galactose as desired. HEp-2 cells (ATCC: # CCL-
23) were routinely cultured in DMEM medium (Invitrogen)
supplemented with 10% fetal calf serum (FCS; Invitrogen).
DNA Manipulation, Library, and Plasmid
Constructions
pSR1 (HIS3 GAL1-His6 2 µ), a p423GAL1-derived plasmid
(Mumberg et al., 1994) bearing a PCR-amplified cassette (Start
codon-linker-his6 tag-3 stop codons for 3 frames) into the
EcoRV site, was used for constructing the P. aeruginosa PA14
genomic library. The library used in this study was constructed
(by AGWOA GmbH, Germany) as follows: P. aeruginosa PA14
genomic DNA was prepared following the protocol in Current
Protocols in Molecular Biology, 1997 (Unit 2.4) (Wilson, 2001).
The obtained pelleted DNA was then resuspended in TE and
then fragmented by sonication into 500–1000 bp sections and
inserted into EcoRV site of the library empty vector pSR1
(constructed by AGWOA GmbH, Germany). Construction of
plasmids used in cellular localization experiments are described
in the supplementary text.
To generate pec2 deletion, 500 bp upstream, and
500 bp downstream of the pec2 gene (PA14_03100)
were amplified by overlapping PCR with High Fidelity




CCG3′ and TSO90 (5′ACTGGCCGTCTTCCACGACCG3′).
The PCR product was cloned in pCR2.1 (TA cloning kit;
Invitrogen) giving pTS39, which was then sequenced (GATC)
and sub-cloned in pKNG101 suicide vector (Kaniga et al., 1991)
giving the mutator pTS41. pTS41, maintained in the E. coli
CC118λpir strain, was mobilized in the wild type P. aeruginosa
strain PA14. The mutants, in which the double recombination
events occurred that resulted in the nonpolar deletion of pec2
gene (PA14_03100), were verified by PCR using external primers
TSO99 (5′GCCCTGGGCAAGTTGCTGCG3′) and TSO100
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(5′GAGGGTGGCATCGCGGTCGG3′). Full length genes of
P. aeruginosa PA14 was cloned in yeast and human expression
vectors are described in details in Supplementary Information.
Screening of P. aeruginosa Genomic
Library in Yeast
1.14µg of the library (representing 3 times coverage of the
PA14 genome) was transformed into yeast and platted onto non-
inducing media agar plates. The screen was then processed in
3 steps. First, the expression of the transformed fragments in
obtained yeast transformants was induced by transferring yeast
colonies via replica platting onto media agar plates containing
2% of the inducer galactose. To assess the impact of expression of
library inserts on yeast growth, Phloxin B that stains dead cells in
pink was added to the media. Colonies on inducing media were
compared to their replicates on non-inducing media and those
that did not grow, displayed smaller size and/or increased pink
staining on inducing media plates were selected. These initial
candidates were then subjected to a secondary screen by the serial
dilution patch test. In this assay, a series of yeast cell dilutions was
dropped on non-inducing and inducing media and the growth
of yeast cells, represented by the number and size of colonies
in comparison to control cells, was assessed. Yeast candidates
showing a growth arrest phenotype were selected. Plasmid DNA
was then isolated from each yeast colony and transferred into
competent E.coli cells. Plasmids from E.coli strains (from at
least 3 E.coli transformants for each yeast candidate) were
isolated and restriction analysis performed to identify those
yeast candidates harboring plasmids carrying different inserts.
Individual plasmids were then transformed into yeast and
subjected to a tertiary screen consisting in a serial dilution
patch test. Plasmid inserts from yeast candidates showing a
growth phenotype were isolated and their P. aeruginosa PA14
genomic fragment were sequenced and corresponding genes
were subjected to further analysis.
Serial Dilution Patch Test
Patch tests were performed with dilution series prepared from
yeast cultures in exponential phase (OD600: ∼ 0.9) grown in SD-
HIS supplemented with 2% raffinose. Dilutions were then spotted
on either selective agar medium (SD-HIS) supplemented with
2% raffinose or galactose and the plates were incubated at 30◦C
for 48 h.
Transfection and Staining of HEp-2 Cells
HEp-2 cells grown overnight on coverslips were transfected with
1µg of the desired DNA plasmid using Turbofect (Thermo
Scientific) as recommended by the manufacturer. After the
desired time (see Figure legends) at 37◦C with 5% CO2, cells
were washed with 1x PBS, fixed in 3.7% paraformaldehyde.
For staining of microtubule, γ-tubulins or peroxisomes, cells
were permeabilized with 0.1% Triton X-100, incubated with
a monoclonal mouse anti-alpha tubulin (Acris), a monoclonal
mouse anti-γ-tubulins (Sigma-Aldrich) or a monoclonal mouse
anti-PMP70 primary antibodies (Sigma-Aldrich), and then with
proper labeled secondary antibodies. To stain lipid droplets,
fixed HEp-2 cells were permeabilized with 0.5% saponin and
stained with Bodipy 493/503 (Molecular Probes). Actin staining
of human cells with rhodamine-phalloidin was performed as
described by the manufacturer (Molecular Probes). DNA was
stained with Dapi. Microscopy was carried out using either
spinning-disk confocal microscopes (Carl Zeiss).
Cytotoxicity Assay
The cytotoxicity of the parental PA14 strain and, its isogenic pec1-
3 insertional mutants were assayed by using murine RAW 264.7.
RAW macrophages were routinely grown in 96-well plates in
Dulbecco modified Eagle medium, GlutaMAX, sodium pyruvate,
and phenol red supplemented with 10% FBS. Prior to infection,
confluent RAW cells were washed twice with sterile PBS and
incubated in RPMI 1640 medium without phenol red. The wild-
type P. aeruginosa and the pec insertional mutants were grown
overnight in TSB and sub cultured into fresh TSB to early
stationary growth phase, washed with sterile PBS twice, and
resuspended in RPMI 1640 medium devoid of FBS. Macrophages
cells were infected with bacteria at a Multiplicity of Infection
(MOI) of 20 for 45min at 37◦C in 5% CO2 incubator. After a
centrifugation at 190 X g to sediment the infected cells, 100µL of
culture supernatants were collected and transferred in a new 96-
well plate. The release of the cytosolic LDH into the supernatant
was measured using a Roche LDH kit in accordance with the
manufacturer′s instructions. Percentage of LDH release was
calculated relative to that of the uninfected control, which was set
at 0% LDH release, and that of lysed uninfected cells, which was
set at 100% LDH release. For statistics, a Dunnett′s test has been
performed as part of One-Way ANOVA using GraphPad Prism.
C. elegans Virulence Assay
The slow killing assay was performed as described previously
with modifications (Zaborin et al., 2009). Each independent
assay consisted of three replicates. E. coli OP50 was used as a
control. L4 to adult stage C. elegans were removed from food
and placed on unseeded NGM plates for 24 h at 25◦C. 50 worms
were then picked onto plates containing overnight growth of
each bacterial strain. The worms were evaluated for viability
on a daily basis. The assay was performed three times. Animal
survival was plotted using the PRISM 5.0 program. Survival
curves were considered significantly different from the control
when p-values were <0.05. PRISM calculated survival fractions
using the product limit (Kaplan-Meier) method and compared
survival curves by two methods: the log-rank test (also called the
Mantel-Cox test) and the Gehan-Breslow-Wilcoxon test. When
necessary Gentamicin was used at 15µg/ml.
RESULTS
P. aeruginosa PA14 Genome-wide Screen
in Yeast Identifies Genes that Alter Yeast
Growth
To identify bacterial proteins that perturb essential and
conserved eukaryotic processes, we constructed a genomic
library of the P.aeruginosa PA14 strain and performed
a three steps genome-wide screen in yeast for bacterial
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FIGURE 1 | Scheme of the genome wide screen of P. aeruginosa PA14 in yeast. The correlation between amount of library DNA and genome fold was
determined by transforming yeast cells with serial dilutions of the library DNA and counting the resulting yeast transformants. Having the correlation established,
1.14µg of the library DNA (representing 3 times coverage of the PA14 genome) was transformed into yeast cells (A). For the primary screen, transformed yeast cells
were selected on a synthetic defined medium lacking histidine (SD-HIS) supplemented with raffinose (B). Yeast colonies obtained ∼1.3 105 transformants,
representing approximately 2.3 times of the PA14 genome) were transferred by replica platting to a solid SD-HIS containing galactose and Phloxine B medium (C),
arrows and numbers (1, 2, and 3) in (C) represent examples for growth phenotypes observed (non-growing, dead phloxine-positive and smaller colonies, respectively),
see also Figure S1. Colonies showed growth phenotype (1186 candidates) were streaked out on plates (SD-HIS) supplemented with raffinose (D). For the secondary
screen, independent candidates from (D) were subjected to serial dilution patch test and positive Pseudomonas effector candidates were selected (E). Plasmids were
then isolated (F) for the tertiary screen and differentiated by restriction analysis (G). Plasmids were retransformed into yeast (H) and transformants from each
candidate were subjected for serial dilution patch test. Fifty four candidates showed growth phenotype (I).
genomic fragments inducing a yeast growth phenotype. After
transforming the library into yeast and platted onto non-
inducing media agar plates (Figure 1A), approximately 1.3× 105
yeast colonies were obtained indicating that at least the equivalent
of 2.3-fold of the P. aeruginosa genome was actually transformed
(Figure 1B). The screen was then processed in 3 steps. In the first
step (Figures 1C,D), we performed a primary negative selection
by transferring yeast colonies via replica platting onto media
agar plates containing galactose and Phloxin B (Figure 1C). We
identified and isolated 1186 colonies that did not grow, displayed
smaller size and/or increased pink staining on inducing media
plates (Figures 1C,D and Figure S1). In the secondary screen,
performed by a serial dilution patch test, we selected among the
1186 primary candidates, 257 secondary candidates showing
a growth arrest phenotype (Figure 1E). Restriction analysis
of plasmid DNA from the 257 yeast candidates revealed that
38 yeast candidates harbored two different plasmids that
carried two different inserts, resulting in a total of 295 plasmids
(Figures 1F,G). Finally, in the tertiary screen, among the 295
plasmids retransformed in yeast (Figure 1H), 54 potential P.
aeruginosa PA14 genomic fragment carrying-plasmids showed a
growth phenotype defect by serial dilution patch test (Figure 1I).
All plasmid inserts were sequenced and corresponding genes
were subjected to further analysis.
Evaluation of the Screen and In silico
Analysis for Selection of Potential
Candidates
The genes covered by the sequence of the 54 P. aeruginosa PA14
inserts were identified using BLAST. Sequence analysis revealed
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that three different regions of the genome were found twice in
the screen. Further in silico analysis revealed that six inserts
harbored sequences from two neighboring ORFs, while six other
inserts carried ORFs in the wrong orientation or only non-coding
sequences and therefore were excluded from further analysis.
We thus revealed 51 unique PA14 ORFs inducing a growth
phenotype in yeast (Figure 2A and Table S1).
Interestingly, 3 out of the 51 candidates have already been
experimentally demonstrated to be secreted exoproteins of
P. aeruginosa (Figure 2A). The non-hemolytic phospholipase C
PlcN (PA14_21110), secreted by the Type II secretion system
(T2SS) (Voulhoux et al., 2001), the Type I secretion system
(T1SS) effector of unknown function AprX (PA14_48140)
(Duong et al., 2001), and the protease LepA (PA14_58900),
secreted by a Type V secretion system (T5SS) and contributing
to the virulence of P. aeruginosa toward human bronchiole
epithelial cells (Kida et al., 2008).
In order to discriminate the cytotoxicity mediated by true
virulence factors from the one due to the ectopic expression
of gene fragments that results in nonspecific growth defect,
the 51 gene candidates previously selected were in silico
screened for features that could classified them as potential new
virulence factors such as secreted proteins of unknown function
linked to Pseudomonas pathogenicity. We thus selected among
the 26 hypothetical proteins (Pseudomonas genome database
website, Pseudomonas.com) (Table S1) the most likely secreted
candidates. To do so, we performed further in silico analysis
based on the criteria that secreted factors are mainly soluble
proteins. Using Phobius (Kall et al., 2004) and TopPred 0.01 (von
Heijne, 1992) programs, 7 soluble proteins of unknown function
were predicted (in bold, Figure 2A), PA14_66480, PA14_36450,
PA14_07450, PA14_03980, PA14_48140 (AprX) PA14_52910 and
PA14_03100. Among them, the corresponding gene encoding
PA14_52910 has been shown to be up regulated under contact
with cultured primary differentiated human airway epithelia
(Chugani and Greenberg, 2007) as well as in the murine chronic
wound infection model (Turner et al., 2014). Moreover, a recent
study revealed that this protein is also essential for colonization
of the murine gastrointestinal track by P. aeruginosa (Skurnik
et al., 2013). Thus, candidate PA14_52910 constitutes a putative
new secreted virulence factor and therefore was termed Pec1
(P. aeruginosa PA14 effector candidate 1, Figure 2B). In addition,
the predicted secreted protein of unknown function PA14_03100
has a putative eukaryotic-like domain (Suppressors of fused
protein, SUFU) known to repress the Hedgehog signaling
pathway, a key regulator of animal development (Taylor et al.,
2002), thus constituting a clue to also consider it as a strong
effector candidate (Pec2, Figure 2B).
We also searched using the program IslandViewer (http://
www.pathogenomics.sfu.ca/islandviewer/query.php (Langille
and Brinkman, 2009) if any of the 51 ORFs located within a
known or predicted genomic pathogenicity island. Our search
revealed that ORF PA14_48530 is found within such a predicted
island. Moreover, the corresponding gene has been shown to be
up regulated in the murine chronic and burn wound infection
models (Turner et al., 2014). Finally and interestingly, this
protein (Pec3, Figure 2B) which is a putative AMP-binding
protein, is also predicted to be soluble making it an interesting
effector candidate as well.
Expression of Full Length pec Genes in
Yeast Induces Growth Defect Phenotype
Expression of pec1,pec2, and pec3 from the original screen
plasmids resulted in impaired yeast growth (Figure 3A). In order
to test whether the expression of full length pec genes also
would impair yeast growth, we produced the full length Pec1,
FIGURE 2 | In silico sorting of the 51 selected candidates. (A) List of the 51 selected candidates. Among the hypothetical proteins (in bold), the soluble ones are
in bold. The three known secreted proteins of P. aeruginosa as well as the three selected Pecs proteins are indicated by their names. (B) Summary of the
characteristics of the 3 selected Pecs. 1TopPred 0.01 (von Heijne, 1992); 2Phobius (Kall et al., 2004) and; 3(Chugani and Greenberg, 2007); 4(Turner et al., 2014);
5(Skurnik et al., 2013); 6PFAM (Taylor et al., 2002); 7 IslandViewer (Langille and Brinkman, 2009).
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FIGURE 3 | Yeast growth phenotype induced by expression of selected pec genes in yeast. (A) Serial dilution patch test of yeast cells carrying the empty
vector (control) or the 3 selected candidates obtained from the screen (Pec1, Pec2, and Pec3). Cells were dropped on selective non-inducing medium (Glucose) or
selective induced medium (Galactose) as indicated. (B) Serial dilution patch test of yeast cells carrying the empty plasmid (control) or full length genes of the 3
selected candidates (Pec1, Pec2, and Pec3). Cells were dropped on selective induced medium (Galactose) as indicated.
FIGURE 4 | Involvement of Pec1 and Pec3 in cytotoxicity against
macrophages. RAW264.7 macrophages were infected with the parental
P. aeruginosa PA14 strain (wtPA14), the negative controls lacking exoU gene
(PA14::tn-exoU) and a non-toxic E. coli strain (TG1), the PA14 strains bearing a
transposon in pec1 (PA14::tn-pec1), pec2 (PA14::tn-pec2), or pec3
(PA14::tn-pec3) at an MOI of 20 during a 45min. Cytotoxicity was measured
with LDH release assay. Percentage of cytotoxicity is shown on the vertical
axis. Error bars show standard deviation. Data shown are representative of
four independent experiments. **** for P < 0.0001; ** for P < 0.01; * for
P < 0.1; ns for non-significant.
Pec2, and Pec3 proteins in yeast and tested them by serial
dilution patch tests (Figure 3B). In comparison to the yeast
growth phenotypes induced by the initial screen plasmids, the
production of full length Pecs showed a significant but attenuated
yeast growth defect phenotype, as detectable by smaller and
less numerous colonies. These differences in growth are likely
due to alterations in protein production levels, protein folding
and/or protein modification. We checked by sequencing that the
differences in growth of yeast cells expressing full length and
genomic fragment of Pec1 and Pec2 were not due to enhanced
translation given by additional genes or small RNAs within the
cloned fragments (data not shown). We therefore concluded
that expression of the 3 full-length pec genes validated the
original yeast growth phenotype, supporting their possible role
as P. aeruginosa virulence factors.
Involvement of Pec1 and Pec3 in
P. aeruginosa Cytotoxicity Toward
Macrophages
We further assessed the role of the Pecs on a crucial aspect
of host pathogen interaction, the killing of macrophages by
P. aeruginosa. In this respect, we compared the cytotoxicity
toward RAW264.7 macrophages of the wild type PA14 strain
with 3 isogenic pec mutants. The release of cytosolic lactate
dehydrogenase (LDH) was measured after 45min of macrophage
infection at a MOI (Multiplicity of Infection) of 20. The pec
mutant strains used in this assay belong to the PA14 transposon
mutant library generated by Liberati et al. (2006). A significant
reduction in cytotoxicity was observed in strains with transposon
insertions in pec1 (PA14 tn-pec1) and pec3 (PA14 tn-pec3) while
the transposon insertion in pec2 (PA14 tn-pec2) displayed a wild
type phenotype (Figure 4). As a positive control, we used the
transposon mutant of the library carrying an insertion in exoU,
the gene encoding the potent cytotoxin ExoU secreted by the
Type III secretion system (T3SS) (Hauser, 2009). This mutant
presents a strong defect in cytotoxicity against macrophages,
thus validating our assay as well as the transposon library. It is
moreover not surprising that, although statistically significant,
the effects of the Pecs found toward macrophages are relatively
weak since most of the P. aeruginosa PA14 cytotoxicity is due
to ExoU (Figure 4). Through this result we showed that, in
agreement with their toxicity in yeast, the selected candidates
Pec1 and Pec3 are novel P. aeruginosa effectors involved in the
cytotoxicity toward macrophages.
The 3 Selected Pecs Contribute to
P. aeruginosa Virulence in the
Caenorhabditis ElegansWorm Model
The involvement of Pecs in P. aeruginosa pathogenicity led
us to test their role in virulence in the C. elegans model.
Previous studies have shown that C. elegans is a good model
to identify P. aeruginosa virulence factors important for
mammalian virulence (Garvis et al., 2009; Feinbaum et al.,
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FIGURE 5 | Involvement of Pec1, Pec2, and Pec3 in PA14 virulence in
the C. elegans model. Impairment of pec1, pec2, and pec3 decreases the
ability of P. aeruginosa to kill C. elegans in a slow killing assay. Worms were
infected with the positive control constituted by the parental P. aeruginosa
PA14 strain (wtPA14), the negative control lacking gacA (PA141gacA) and the
PA14 strains bearing a transposon in pec1 (PA14::tn-pec1), pec2
(PA14::tn-pec2), or in pec3 (PA14::tn-pec3) (A) or lacking pec2 (PA141pec2)
(B). The percentage of surviving nematodes is shown with respect to the
number of days post-infection. Data presented are representative of at least
two independent experiments. See text for P-values.
2012; Sana et al., 2012, 2013). In a slow killing assay, we
observed, in agreement with the cytotoxicity assays, that
strains PA14::tn-pec1 and PA14::tn-pec3 were significantly less
virulent than the PA14 wild type strain [P < 0.001 (∗∗∗)]
(Figure 5A) thus confirming that Pec1 and Pec3 are virulence
factors. Interestingly, Pec2 also contributes to P. aeruginosa
virulence in this model [P < 0.001 (∗∗∗)] revealing that
Pec2 is also a virulence factor, although harmless against
macrophages. The parental wild type PA14 P. aeruginosa
strain was used as positive control while the non-virulent
PA14 P. aeruginosa strain (PA141gacA) was used as negative
control.
In order to exclude any polar effect on downstream genes
due to the transposon insertion in the pec gene, we constructed
an in frame pec2 deletion mutant (PA14 1pec2). The attenuated
virulence observed with PA14::tn-pec2 strain was confirmed with
the pec2 full deletion mutant [P < 0.01 (∗∗)] (Figure 5B).
However, since we were unable to generate in frame deletions
of pec1 and pec3, we cannot exclude any polar effect in these
cases. It is however unlikely that the reduction of cytotoxicity
and virulence observed in PA14::tn-pec1 and PA14::tn-pec3 is not
due to pec1 and pec3 gene products since they are toxic when
expressed in yeast. All together we have shown by two different
and independent approaches that the 3 effectors selected in our
yeast screen are true new P. aeruginosa virulence factors that
contribute to the P. aeruginosa cytotoxicity against macrophages
and/or virulence on the C. elegansmodel.
Subcellular Localization Studies of Pecs
after Expression in Yeast and Human Cells
In order to validate that Pecs have subcellular targets in host
cells, we cloned the 3 pec genes required for P. aeruginosa
PA14 infectivity in human expression vectors and transfected
them into HEp-2 cells for subsequent analysis by spinning disk
microscopy.
GFP-Pec3 Diffuses in HEp-2 Transfected Cells
Ectopic production of GFP-Pec3 in epithelial cells showed a
diffuse GFP pattern similar to GFP expressing control cells
indicating no particular localization of this effector (Figure 6). A
similar localization pattern was also observed in yeast (data not
shown). These results suggest that the target of Pec3 cannot be
identified by localization studies.
YFP-Pec1 Localizes to Microtubule Organizing
Center (MTOC) in HEp-2 Transfected Cells
Ectopic production of YFP-Pec1 in HEp-2 cells for 15 h revealed
a punctuate staining mainly with 1–4 signals per cell. Often
the YFP-Pec1 dots were found to be associated with nuclei and
quantification revealed that in more than 50% of transfected cells
the dots were located on opposite sides of the nucleus (indicated
by arrows in the upper panel of Figure 7A, MIP merge). Longer
expression time (30 h) resulted in an increase in the number
of dots (up to 20 signals) occasionally showing some clustering
mostly associated with the nuclei (indicated by arrowheads in
the lower panel of Figure 7A). In particular, the 15 h localization
pattern was reminiscent of the localization of the microtubule-
organizing center (MTOC). Therefore we investigated whether
YFP-Pec1 is colocalizing with γ-tubulin which is a central
component of the MTOC (Kollman et al., 2011). Control
cells producing YFP alone showed 1–4 γ-tubulin signals per
cell (Figure 7B, upper panel). After 15 and 30 h of YFP-Pec1
production, we observed γ-tubulin signals in most cells and the
YFP-Pec1 producing cells showed the γ-tubulin signals directly
attached to or near (1–3.2µm) the accumulating YFP-Pec1
signals (Figure 7B, middle and lower panels). Quantification
revealed that 74 and 60% of the transfected cells showed
the γ-tubulin signals associated with the fusion YFP-Pec1
after 15 and 30 h of transfection, respectively (Figure 7C left).
However, often cells producing the fusion protein did not show
visible signals of γ-tubulin (indicated by arrows in the lower
panel of Figure 7B). Again quantification revealed that cells
producing the YFP-Pec1 fusion for 30 h concomitantly had lost
the γ-tubulin signals in 21% [P < 0.1 (∗)] of the cells in
comparison to the YFP expressing cases (Figure 7C right). The
results indicate that Pec1 likely is accumulating with γ-tubulin
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FIGURE 6 | Expression patterns of GFP-Pec3 in HEp-2 transfected cells. HEp-2 cells were transfected with a human expression vector carrying GFP or
GFP-Pec3 for 18 h. Cells were then fixed and stained with DAPI (blue) to visualize nuclei and with rhodamine-phalloidin (red) to visualize F-actin.
complexes and negatively influencing their number in transfected
cells.
Tagged-Pec2 is Associated with the
Microtubule/Peroxisome/Lipid Droplet Complex in
HEp-2 Transfected Cells
Human cells transfected with a GFP-Pec2 expression vector
showed punctuate structures of the fusion protein distributed
throughout the cytoplasm (Figure S2A). In order to facilitate the
analysis of Pec2 localization, we first determined the subcellular
localization of GFP-Pec2 in yeast. Yeast cells producing GFP-
Pec2 also showed distinct punctuate structures (1–4 dots per cell,
Figures S2B–D). In order to identify possible yeast structures
colocalizing with these Pec2 signals, we first visualized the yeast
cytoskeleton. While the Pec2 signals did not colocalize with
actin structures which appeared normal in Pec2 expressing yeast
(data not shown), they strikingly associated with microtubules
(MT) (Figure S2B). Further localization studies usingmRFP yeast
reporter strains (in which different cellular compartments are
labeled with mRFP (Huh et al., 2003) revealed that GFP-Pec2
localizes with peroxisomes (Figure S2C) and lipid droplets (LD)
(Figure S2D).
In order to test if these localization patterns of Pec2 in
yeast were also conserved in human cells, we first investigated
the association of the fusion protein GFP-Pec2 with MT.
Fluorescence microscopy confirmed that 97.8% (± 1.67%) of the
GFP-Pec2 protein signals are associated with MT structures in
transfected HEp-2 cells (Figure 8). We also stained transfected
HEp-2 cells for peroxisomes and LD. GFP-Pec2 producing HEp-
2 cells stained with α-PMP70 antibody showed a localization of
83.3% (± 3.53%) of GFP-Pec2 signals to peroxisomes (Figure 8).
Finally the analysis of HEp-2 cells producing mCherry-Pec2
stained with Bodipy showed some association of the GFP-Pec2
fusion signals 58% (± 4.37%) with lipid droplets (Figure 8).
These results suggest that the LD and its associated organelles:
microtubule and peroxisome (Goodman, 2008) are targets for
Pec2.
DISCUSSION
We performed a genome-wide screen of the PA14 P. aeruginosa
genome for bacterial proteins causing a growth inhibition
phenotype in yeast. In contrast to previous studies based on
selected candidates (Sisko et al., 2006; Arnoldo et al., 2008;
Siggers and Lesser, 2008; Curak et al., 2009), the present work
covers the whole genome and aimed at revealing unsuspected
new virulence factors of the human pathogen P. aeruginosa.
Following a 3-stage selection, 51 independent candidates were
finally experimentally selected. One known virulence factor of
P. aeruginosa, the protease LepA, was recovered in the list and
therefore validates the efficiency of our screen. In addition, two
known exoproteins secreted into the extracellular medium by
P. aeruginosa were also highlighted by the screen, the non-
hemolytic phospholipase C PlcN (PA14_21110) and the T1SS
secreted protein AprX (PA14_48140), raising to 3 the number of
secreted exoproteins recovered in our screen. However, and in
contrast to LepA, PlcN, and AprX have not been demonstrated to
be directly involved in P. aeruginosa virulence so far. Our screen
however revealed that they are toxic in yeast and might therefore
constitute new putative virulence factors.
Among the 51 candidates, 3 proteins were specifically selected
as putative Pseudomonas effector candidates (Pec1, Pec2, and
Pec3) and further tested under natural infection conditions.
Our analysis demonstrates the significant contribution of the
three Pecs to virulence in the C. elegans slow killing assay,
while Pec1 and Pec3 also contribute to P. aeruginosa acute
cytotoxicity toward macrophages. These results prove that our
selection procedure, i.e., search for bacterial ORFs inducing
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FIGURE 7 | Ectopic production and localization of YFP-Pec1 in human transfected cells. (A) HEp-2 cells were transfected with YFP-Pec1 expressing vector
for 15 h (upper panels) or 30 h (lower panels). YFP-Pec1 (green) accumulates at the nucleus poles (blue) (indicated by arrows and arrowheads in the upper and lower
panels, respectively). Actin filaments (F-actin) in red. Data shown are maximum intensity projection (MIP) images or single z-sections as indicated. (B) Transfected
HEp-2 cells expressing YFP (green) or YFP-Pec1 (green) for 15 and 30 h as indicated, were stained with anti-γ-tubulins antibody (red) to identify MTOC (arrows
indicate transfected cells that lost the γ-tubulins signal). (C) MTOC associated with YFP-Pec1 (green) and transfected cells showed stained γ-tubulins was quantified
(upper and lower graphs, respectively). The data are expressed as the means ± SEM (n = 3, each involving observation of 50 transfected cells). *P < 0.1.
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FIGURE 8 | Association of Pec2 with microtubules, peroxisomes, and lipid droplets. HEp-2 cells were transfected with either GFP-Pec2 (green, upper, and
middle panels) or mCherry-Pec2 (red, lower panels) for 18 h. Transfected cells were then fixed and labeled with either anti-alpha-tubulin (upper panels) to visualize
microtubules, anti-PMp70 (middle panels) to visualize peroxisomes or Bodipy 493/503 (lower panels) to visualize lipid droplets (green). The enlarged images of single
z-sections correspond to the boxes in the MIP images.
growth phenotype when expressed in yeast, followed by the
in silico sorting of hypothetical soluble proteins is efficient to
select true virulence factors. Interestingly, while required for
P. aeruginosa virulence in the wormmodel, Pec2 has no influence
on the cytotoxicity toward macrophages, which may suggest that
Pec2 does not naturally target this kind of immune cells. This
is indeed the case for the H2- and H3-T6SS (Type VI secretion
systems) and their cognate virulence effectors that are required
for internalization of P. aeruginosa into epithelial cells but display
no cytotoxicity against phagocytic cells (Sana et al., 2012, 2015;
Jiang et al., 2014).
We are aware that the stringency of the whole candidate
selection procedure followed during this screen may have led
to the exclusion of additional virulence factors. Therefore, a
different in silico selection leading to other Pecs from the 51-
list could have been done using alternative criteria. Indeed,
not all bacterial soluble translocated proteins necessarily inhibit
yeast growth. A previous study indeed showed that only half of
the 19 known Shigella translocated proteins tested significantly
inhibit yeast growth (Slagowski et al., 2008). Thus, it would be
interested in the future to test the complete initial list of 51
effector candidates.
The most potent Pseudomonas cytotoxin, ToxA (69 kDa) and
ExoU (74 kDa) (Bleves et al., 2010) have not been recovered
in our screen. This could be due to the size-limitation of the
genomic fragment expressed by the library (maximum 1000 bps
equivalent to 37KDa), which does not allow the production of
full length ToxA and ExoU which apparently need to be full size
to be active. This is however not the case for LepA (140 kDa),
PlcN (77 kDa), and AprX (41 kDa) since the production of an
internal fragment is sufficient to mediate cytotoxicity in yeast.
Interestingly, this internal domain does not contain the serine
protease or the cell attachment motifs identified in LepA (Kida
et al., 2008) and have no homology to any known functional
domains. Its toxic activity is therefore carried through an
unknown mechanism.
The size fragment limitation of our screen can moreover
explain why none of the nine ORFs (including exoU) that
impaired the yeast growth in a previous similar yeast phenotype
screen (Arnoldo et al., 2008) was recovered in our screen.
Interestingly, none of the 51 Pecs revealed in our study was
recovered in Arnoldo’s screen (Arnoldo et al., 2008) which was
restricted to 505 pre-selected candidates, thus highlighting a
novel list of effector candidates never suspected before.
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Since Pec1, Pec2, and Pec3 are predicted soluble proteins,
toxic when produced in yeast and contribute to P. aeruginosa
virulence, we have postulated that they are secreted virulence
factors. In this respect, we extensively tried to show their
secretion in the extracellular medium by P. aeruginosa. Thanks
to specific antibodies raised against Pec1, Pec2, and Pec3 we have
tried to detect them in the supernatant of various planktonic
cultures of P. aeruginosa. Unfortunately we were unable to
detect any of the Pecs inside or outside the bacterium (data
not shown). This result suggests that pec genes are subject
to a specific regulation mechanism inactive under planktonic
conditions. This is in line with the host contact-dependent
induction of pec1 reported by Chugani and Greenberg (2007).
We have thus cloned and over-expressed in P. aeruginosa the 3
corresponding pec genes. Although they are properly produced
(data not shown), none of the artificially overproduced Pecs were
detected in the extracellular medium. While we cannot exclude
that Pecs are non-secreted effectors, we favor the possibility
that they require partners and/or secretion machines subject to
similar regulatory process and therefore not produced under the
artificial growth conditions used. We also cannot exclude that
they need a host factor for stability explaining why we do not
detect them in the extracellular medium. Finally, since the 3
selected Pecs are lacking signal peptides, they most likely do not
use T2SS or T5SS for their secretion. Understanding the secretion
pathway undertaken by the Pecs will certainly provide important
information on the mode of action of those 3 P. aeruginosa
virulence factors.
Ectopically produced Pecs in HEp-2 cells revealed specific
cellular localization for Pec1 and Pec2 After 15 and 30 h of
expression of YFP-Pec1 in HEp-2 cells, dot-like structures are
visible and about 60% of the fusion protein locates closely
adjacent to the MTOC signal. Moreover, 21% of the cells
expressing the fusion protein show absence of the MTOCmarker
γ-tubulin. This suggests that Pec1 could target the host MTOC.
HEp-2 cells expressing the tagged Pec2 showed the fusion protein
as punctuate structures all over the cytosol and associated with
LDs and its associated organelles including MT and peroxisomes
(Goodman, 2008). As vesicle transport is mediated by the
host cytoskeleton, the Pec2 producing pattern might suggest
an involvement of the protein in MT-dependent transport of
LD and/or peroxisomes during infection. Recruitment of MT-
based activities has been reported for a number of pathogens
(Radhakrishnan and Splitter, 2012). To explain why GFP-Pec
reporter fusions are not toxic when produced in yeast of
mammalian cells, it should be noted that expression of GFP-Pec2
from the single copy plasmid used for localization experiments
resulted in a very weak or normal growth in yeast compared to
the 2µ vector used to screen the library (data not shown). In
general, the localization pattern of ectopically expressed effector
proteins can provide novel insights into pathogenic strategies
exerted by pathogens. For example, the localization of the
Chlamydia Lda3 protein with yeast and human lipid droplets has
led to the discovery of LD consumption by Chlamydia (Sisko
et al., 2006; Cocchiaro et al., 2008). The fact that Pec1 and
Pec2 are associated with host cellular organelles might lead us
to investigate the role of the new host targets which will extend
our understanding of the molecular mechanisms involved in the
P. aeruginosa infection.
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